Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yinnan Meng
Observed name:
Y. Meng
Institutions:
University of Hong Kong - Shenzhen Hospital,
University of Hong Kong
Observed institutions:
University of Kentucky,
Wenzhou Medical University,
University of Hong Kong - Shenzhen Hospital,
Zhejiang Taizhou Hospital,
University of Hong Kong
ORCID:
0000-0002-8203-820X
Observed ORCID:
0000-0002-8203-820X
OpenAlex ID:
A5003336727
GBP1 Facilitates Indoleamine 2,3-Dioxygenase Extracellular Secretion to Promote the Malignant Progression of Lung Cancer
2021
·
Yinnan Meng
, Wei Wang
, et al.
·
Frontiers in Immunology
·
36
PDF
Adaptive intensity-modulated radiotherapy with simultaneous integrated boost for stage III non-small cell lung cancer: Is a routine adaptation beneficial?
2021
·
Yinnan Meng
, Wei Luo
, et al.
·
Radiotherapy and Oncology
·
33
PDF
Treatment-Related Pneumonitis of EGFR Tyrosine Kinase Inhibitors Plus Thoracic Radiation Therapy in Patients With Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
2023
·
Yinnan Meng
, Han Sun
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
28
Enhanced CT-Based Radiomics to Predict Micropapillary Pattern Within Lung Invasive Adenocarcinoma
2021
·
Yunyu Xu
, Wenbin Ji
, et al.
·
Frontiers in Oncology
·
25
PDF
Excluding PTV from lung volume may better predict radiation pneumonitis for intensity modulated radiation therapy in lung cancer patients
2019
·
Yinnan Meng
, Haihua Yang
, et al.
·
Radiation Oncology
·
25
PDF
Reduced PHLPP Expression Leads to EGFR-TKI Resistance in Lung Cancer by Activating PI3K-AKT and MAPK-ERK Dual Signaling
2021
·
Wei Wang
, Xinhang Xia
, et al.
·
Frontiers in Oncology
·
23
PDF
CT-based radiomics nomogram may predict who can benefit from adaptive radiotherapy in patients with local advanced-NSCLC patients
2023
·
Chao Zhou
, Liqiao Hou
, et al.
·
Radiotherapy and Oncology
·
22
Radiotherapy improves the outcomes of immunotherapy with Sintilimab in non-small-cell lung cancer: A real-world analysis
2022
·
Shuling Li
, Kuifei Chen
, et al.
·
Frontiers in Immunology
·
19
PDF
Intermediate Dose-Volume Parameters, Not Low-Dose Bath, Is Superior to Predict Radiation Pneumonitis for Lung Cancer Treated With Intensity-Modulated Radiotherapy
2020
·
Yinnan Meng
, Wei Luo
, et al.
·
Frontiers in Oncology
·
17
PDF
Endostar improved efficacy of concurrent chemoradiotherapy with vinorelbine plus carboplatin in locally advanced lung squamous cell carcinoma patients with high serum Lp(a) concentration
2020
·
Hailing Xu
, Dongqing Lv
, et al.
·
Annals of Palliative Medicine
·
14
PDF
The Critical Components for Effective Adaptive Radiotherapy in Patients with Unresectable Non-Small-Cell Lung Cancer: Who, When and How
2022
·
Suna Zhou
, Yinnan Meng
, et al.
·
Future Oncology
·
11
Synergistic Antitumor Effects of Anlotinib Combined with Oral 5-Fluorouracil/S-1 via Inhibiting Src/AKT Signaling Pathway in Small-Cell Lung Cancer
2022
·
Xinhang Xia
, Wenhu Pi
, et al.
·
Analytical Cellular Pathology
·
11
PDF
FLVCR1 Predicts Poor Prognosis and Promotes Malignant Phenotype in Esophageal Squamous Cell Carcinoma via Upregulating CSE1L
2021
·
Suna Zhou
, Mingxin Zhang
, et al.
·
Frontiers in Oncology
·
11
The prognostic value of circulating lymphocyte counts and ABO blood group in lung cancer stereotactic body radiation therapy: a retrospective study
2022
·
Meng Chen
, Kuifei Chen
, et al.
·
Journal of Thoracic Disease
·
10
PDF
Radiation-induced lung damage in patients treated with stereotactic body radiotherapy after EGFR-TKIs: is there any difference from stereotactic body radiotherapy alone?
2021
·
Xingni Tang
, Yichao Shen
, et al.
·
Annals of Palliative Medicine
·
9
PDF
A Novel Prognosis Signature Based on Ferroptosis-Related Gene DNA Methylation Data for Lung Squamous Cell Carcinoma
2022
·
Xuequan Wang
, Yinnan Meng
, et al.
·
Journal of Oncology
·
7
PDF
Effect of radiation fractionation on IDO1 via the NF-κB/COX2 axis in non-small cell lung cancer
2023
·
Yanli Lan
, Wenhu Pi
, et al.
·
International Immunopharmacology
·
6
Efficacy and Failure Patterns of Early SBRT to the Primary Tumor in Advanced EGFR-Mutation-Positive Lung Cancer with EFGR-TKI Treatment: A Prospective, Single Arm, Phase II Study
2022
·
Yangyang Shi
, Hailing Xu
, et al.
·
Life
·
6
PDF
DNA Repair Genetics and the Risk of Radiation Pneumonitis in Patients With Lung Cancer: A Systematic Review and Meta-analysis
2024
·
W.S. Yiu
, T.S.M. Chu
, et al.
·
Clinical Oncology
·
5
P2.01-124 SIB-IMRT in Symptomatic Brain Metastases for NSCLC: A Randomized Controlled Study of WBRT Comparing 25Gy and 30Gy
2018
·
J. Zhu
, Q. Dong
, et al.
·
Journal of Thoracic Oncology
·
2
P1.03-17 Function of Antisense LncRNA RP11-539E17.5 and FAM83A-AS1 Up-Regulating FAM83A in Lung Adenocarcinoma Tumorigenesis and Development
2019
·
X. Wang
, W. Wang
, et al.
·
Journal of Thoracic Oncology
·
1
PDF
P1.04-69 Modelling the Immunosuppressive Difference of SBRT and CRT by Simulating the Dose to Circulating Lymphocytes in Non-Small Cell Lung Cancer
2019
·
Y. Shen
, Y. Meng
, et al.
·
Journal of Thoracic Oncology
·
1
PDF
Dose calibration uncertainty and plan-specific dose calibration for IMRT QA
2018
·
Wei Luo
, Yinnan Meng
, et al.
·
Biomedical Physics & Engineering Express
·
1
PDF
Supporting data for "Radiotherapy-Induced Lung Toxicity and Immune Landscape Reshaping in EGFR-Mutated Non-Small Cell Lung Cancer"
2026
·
Yinnan Meng
, Fengming P Kong
·
Figshare
Prophylactic Cranial Irradiation in MRI-Staged Limited-Stage Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Survival and Neurocognitive Outcomes
2026
·
Shaoli Li
, Xin Zheng
, et al.
·
Cancers
Show more works
View as search
Works count:
43
Citation count:
323
H-index:
11
I10-index:
14
Year
Topic
Type